Translating predictive biomarkers within oncology clinical development programs

Biomarkers in Medicine
Robert A Beckman, Cong Chen

Abstract

Predictive biomarkers provide essential information to enable personalized medicine, and hold the promise for enhancing the effectiveness and value of cancer therapies. However, they do not always work. This review provides a framework for managing the risk of predictive biomarkers and maximally harvesting their benefit. Methods are provided which permit data-driven, adaptive decision making about the use of predictive biomarkers during clinical development, applying them to the extent they are validated by the clinical data. Techniques for optimizing overall development efficiency, measured as the number of successful drug indications approved per patient utilized, are also presented.

References

Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Boris Freidlin, Richard Simon
May 27, 2006·Science·William S Dalton, Stephen H Friend
Sep 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Robert A Beckman, Lawrence A Loeb
Sep 19, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia A TangLillian L Siu
Nov 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark J Ratain, Robert H Glassman
Mar 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rafael G AmadoDavid D Chang
Apr 23, 2009·Journal of Biopharmaceutical Statistics·Cong Chen, Robert A Beckman
Oct 10, 2009·Journal of the National Cancer Institute·Richard M SimonDaniel F Hayes
Dec 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David F Ransohoff, Margaret L Gourlay
Jan 16, 2010·Journal of the National Cancer Institute·Boris FreidlinEdward L Korn
Oct 12, 2010·Seminars in Cancer Biology·Robert A Beckman
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Oct 1, 2011·Nature Reviews. Drug Discovery·Robert A BeckmanCong Chen
Feb 11, 2012·Nature Reviews. Drug Discovery·Gary J Kelloff, Caroline C Sigman
Aug 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Robert A BeckmanChen-Hsiang Yeang
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Sep 7, 2013·Nature Reviews. Drug Discovery·Jane FridlyandHoward I Scher
Feb 15, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cong Chen, Robert A Beckman

❮ Previous
Next ❯

Citations

Feb 6, 2016·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·Jeannie RodriguezMarti Rice
Oct 21, 2016·Clinical Pharmacology and Therapeutics·M R TrusheimL J Esserman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nursing Management
Dennis SherrodMechelle Mumford
Onkologie
Dieter Marmé, Michael Hallek
The New England Journal of Medicine
Sridhar Ramaswamy
© 2021 Meta ULC. All rights reserved